
即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.

CAS号 | 1818428-24-8 | 货号 | BCP43165 |
中文名 | EHP-101 | ||
英文名 | EHP-101 | ||
中文别名 | |||
英文别名 | EHP101; EHP 101; VCE-004; VCE004; VCE 004; VCE-004.8; VCE004.8; VCE 004.8; | ||
SMILES | CCCCCC1=C(C(=C(C(=O)C1=O)C2C=C(CCC2C(=C)C)C)O)NCC3=CC=CC=C3 | ||
化学名称 | |||
分子式 | C28H35NO3 | 分子量 | 433.58 |
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | EHP-101 (VCE-004.8) is an orally active, specific PPARγ and CB2 receptor dual agonist. EHP-101 inhibits prolyl-hydroxylases (PHDs) and activates the HIF pathway. EHP-101 attenuates adipogenesis and prevents diet-induced obesity. EHP-101 (20 mg/kg/day; i.p.; for 3 weeks) induces a significant reduction in body weight gain, total fat mass, adipocyte volume and plasma triglycerides levels in HFD mice. |
相关产品推荐
查看更多 >Tags:EHP-101 供应商,EHP-101 购买,EHP-101 生产,EHP-101 批量,EHP-101 供应,EHP-101 订购,EHP-101 采购